The Endocrine Account Manager role is a high-impact position that is critically important to BridgeBio’s success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal dominant hypocalcemia type 1, a rare endocrine disease. They will be patient champions with exceptional business and clinical acumen to execute product launches with sustained excellence. In doing so, they will bring a high sense of urgency, a solution-oriented mindset, and a passion to partner with ADH1 providers and patients. BridgeBio pioneered a “moneyball for biotech” approach in 2015, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. They build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together, they define white space, push boundaries, and empower people to solve problems. They value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior